tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IN:AUROPHARMA Stock Latest News

Aurobindo Pharma to Join Goldman Sachs India Pharma Corporate Days Investor Meet
Company AnnouncementsAurobindo Pharma to Join Goldman Sachs India Pharma Corporate Days Investor Meet
6d ago
Aurobindo Pharma Says Share Volume Surge Is Market-Driven Amid MIP Notification on Key Antibiotics
PremiumCompany Announcements
Aurobindo Pharma Says Share Volume Surge Is Market-Driven Amid MIP Notification on Key Antibiotics
1M ago
Aurobindo Pharma Schedules Q3 FY26 Analyst and Investor Earnings Call
PremiumCompany Announcements
Aurobindo Pharma Schedules Q3 FY26 Analyst and Investor Earnings Call
1M ago
Aurobindo Pharma Says Share Volume Surge Is Market-Driven Amid Antibiotic MIP Move
PremiumCompany Announcements
Aurobindo Pharma Says Share Volume Surge Is Market-Driven Amid Antibiotic MIP Move
1M ago
Aurobindo Pharma Says Surge in Share Volume Is Market Driven, Not Due to Undisclosed Events
PremiumCompany Announcements
Aurobindo Pharma Says Surge in Share Volume Is Market Driven, Not Due to Undisclosed Events
1M ago
Aurobindo’s CuraTeQ Wins Health Canada Nod for Dyrupeg Biosimilar
PremiumCompany AnnouncementsAurobindo’s CuraTeQ Wins Health Canada Nod for Dyrupeg Biosimilar
2M ago
Aurobindo Pharma Shuts Trading Window Ahead of Q3 FY26 Results
Premium
Company Announcements
Aurobindo Pharma Shuts Trading Window Ahead of Q3 FY26 Results
2M ago
Aurobindo Pharma Concludes US FDA Inspection with No Operational Impact
Premium
Company Announcements
Aurobindo Pharma Concludes US FDA Inspection with No Operational Impact
3M ago
Aurobindo Pharma Announces Key Senior Management Changes
PremiumCompany Announcements
Aurobindo Pharma Announces Key Senior Management Changes
4M ago
Aurobindo Pharma Expands into Chilean Market with New Subsidiary
PremiumCompany Announcements
Aurobindo Pharma Expands into Chilean Market with New Subsidiary
5M ago
Aurobindo Pharma Expands into Chile with New Subsidiary
PremiumCompany Announcements
Aurobindo Pharma Expands into Chile with New Subsidiary
5M ago
Aurobindo Pharma Expands into Malaysia with New Subsidiary
PremiumCompany Announcements
Aurobindo Pharma Expands into Malaysia with New Subsidiary
6M ago
Aurobindo Pharma’s Apitoria Unit Completes US FDA Inspection with Procedural Observations
PremiumCompany AnnouncementsAurobindo Pharma’s Apitoria Unit Completes US FDA Inspection with Procedural Observations
6M ago
Aurobindo Pharma to Engage in Virtual Investor Conference
Premium
Company Announcements
Aurobindo Pharma to Engage in Virtual Investor Conference
7M ago
CuraTeQ Biologics Gains EMA Positive Opinion for Dazublys®
Premium
Company Announcements
CuraTeQ Biologics Gains EMA Positive Opinion for Dazublys®
11M ago
Aurobindo Pharma’s Eugia Pharma Gains USFDA Approval for Dasatinib Tablets
PremiumCompany Announcements
Aurobindo Pharma’s Eugia Pharma Gains USFDA Approval for Dasatinib Tablets
11M ago
Aurobindo Pharma Secures USFDA Approval for Rivaroxaban Tablets
PremiumCompany Announcements
Aurobindo Pharma Secures USFDA Approval for Rivaroxaban Tablets
11M ago
Aurobindo Pharma’s US Warehouse Receives OAI Status Post FDA Inspection
PremiumCompany Announcements
Aurobindo Pharma’s US Warehouse Receives OAI Status Post FDA Inspection
1y ago
Aurobindo Pharma to Host Investor Group Plant Visit
PremiumCompany Announcements
Aurobindo Pharma to Host Investor Group Plant Visit
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >